Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 Earnings Call Transcript March 12, 2026
Champions Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $0.09.
Operator: Greetings. Welcome to the Champions Oncology Third Quarter Fiscal Year 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Rob Brainin, CEO at Champions Oncology. You may begin.
Robert Brainin: Good...
